Tech Company Financing Transactions

C16 Biosciences Funding Round

C16 Biosciences, based in New York, raised $4.5 million in funding from Bill & Melinda Gates Foundation and Elemental Excelerator.

Transaction Overview

Company Name
Announced On
1/26/2024
Transaction Type
Debt
Amount
$4,500,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand its platform by working with non-agriculturally derived feedstocks to produce food-grade oils and fats.

Company Information

Company Status
Private & Independent
Industry
Consumer
Mailing Address
444 Somerville Ave.
New York, NY 10014
USA
Email Address
Not Recorded
Overview
C16 Biosciences uses innovative processes found in nature to brew sustainable alternatives to palm oil. Palm oil is everywhere: it's in our food, clothes, shampoo, and even the fuel that powers our cars. C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to conflict palm oil.
Profile
C16 Biosciences LinkedIn Company Profile
Social Media
C16 Biosciences Company Twitter Account
Company News
C16 Biosciences News
Facebook
C16 Biosciences on Facebook
YouTube
C16 Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Shara Ticku
  Shara Ticku LinkedIn Profile  Shara Ticku Twitter Account  Shara Ticku News  Shara Ticku on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/26/2024: Axiom venture capital transaction
Next: 1/26/2024: Sierra venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary